These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30195823)

  • 1. The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016.
    Aryan Z; Mahmoudi N; Sheidaei A; Rezaei S; Mahmoudi Z; Gohari K; Rezaei N; Hajipour MJ; Dilmaghani-Marand A; Razi F; Sabooni M; Kompani F; Delavari A; Larijani B; Farzadfar F
    J Clin Lipidol; 2018; 12(6):1471-1481.e4. PubMed ID: 30195823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population.
    Sharifi F; Mousavinasab SN; Soruri R; Saeini M; Dinmohammadi M
    Metab Syndr Relat Disord; 2008 Sep; 6(3):187-95. PubMed ID: 18774906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran.
    Fesharakinia A; Zarban A; Sharifzadeh GR
    Arch Iran Med; 2008 Nov; 11(6):598-601. PubMed ID: 18976028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.
    Zhang M; Deng Q; Wang L; Huang Z; Zhou M; Li Y; Zhao Z; Zhang Y; Wang L
    Int J Cardiol; 2018 Jun; 260():196-203. PubMed ID: 29622441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between anthropometric parameters and lipid profiles in Chinese individuals with age ≥40 years and BMI <28kg/m2.
    Yang Z; Ding X; Liu J; Duan P; Si L; Wan B; Tu P
    PLoS One; 2017; 12(6):e0178343. PubMed ID: 28632766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.
    Hong N; Lin Y; Ye Z; Yang C; Huang Y; Duan Q; Xie S
    Front Immunol; 2022; 13():937201. PubMed ID: 36032093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
    Zdrojewski T; Solnica B; Cybulska B; Bandosz P; Rutkowski M; Stokwiszewski J; Gaciong Z; Banach M; Wojtyniak B; Pencina M; Wyrzykowski B
    Kardiol Pol; 2016; 74(3):213-23. PubMed ID: 27004543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010.
    Kit BK; Carroll MD; Lacher DA; Sorlie PD; DeJesus JM; Ogden C
    JAMA; 2012 Aug; 308(6):591-600. PubMed ID: 22871871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
    Ali N; Samadder M; Kathak RR; Islam F
    PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
    Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.